Pedunculated hepatocellular carcinoma and splenicmetastasis

Yan, Mao-Lin; Yaodong, Wang; Lai, Zhide; Tian, Yi-feng; Chen, Hongbiao; Qiu, Funan; Zhou, Songqiang

doi:10.3748/wjg.15.5239

Cited by 10 publications

(6 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, the resection rate of P-HCC is high, but the prognosis is poor due to recurrence and metastasis to the peritoneum, adrenal glands, and spleen. 3 , 4 , 5 In our case also, it was difficult to diagnose P-HCC because it was mistaken for a pelvic mass. We describe a case of primary HCC that was detected incidentally during an obstetric operation.…”

Section: Introductionmentioning

confidence: 62%

See 1 more Smart Citation

Giant pedunculated hepatocellular carcinoma masquerading as a pelvic mass: a case report

Jung

2014

Korean J Hepatobiliary Pancreat Surg

View full text Add to dashboard Cite

Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world, with high frequency rates in Asia. Many of the patients have unresectable disease at the time of diagnosis, and early detection and surgical resection is the best hope for survival. But, if HCC is presenting as an extrahepatic mass, the diagnosis is difficult. Herein, we report a case of primary HCC masquerading as a pelvic mass. A 74-year-old woman was admitted to our hospital due to a palpable mass in the lower abdomen. CT scan detected an approximately 15.0×13.4×11.4 cm-sized multilobulated homogeneous enhancing mass in the right adnexa. Operative findings showed that the pelvic mass originated from the liver. We performed hepatic wedge resection. Permanent histopathologic report revealed primary HCC. Exophytic-growing hepatocellular carcinoma should be carefully diagnosed.

show abstract

Section: Introductionmentioning

confidence: 62%

“…It is also misdiagnosed as a splenic or peritoneal mass. 3 , 4 Similarly, it may invade the duodenum and mimic a duodenal gastrointestinal stromal tumor. 15 …”

Section: Discussionmentioning

confidence: 99%

Giant pedunculated hepatocellular carcinoma masquerading as a pelvic mass: a case report

Jung

2014

Korean J Hepatobiliary Pancreat Surg

View full text Add to dashboard Cite

show abstract

“…[ 8 ] In addition, other factors may lead to splenomegaly in patients, such as splenic metastasis of carcinoma, splenic aneurysm, splenic tuberculosis, or splenic hemangioma. [ 9 – 12 ] For patients with tumors, whether there are other mechanisms that cause splenomegaly requires further study.…”

Section: Discussionmentioning

confidence: 99%

Excessive splenic volume is an unfavorable prognostic factor in patients with non-small cell lung cancer treated with chemoradiotherapy

Guo

Wang

et al. 2020

Medicine

View full text Add to dashboard Cite

The relationship between splenic volume and the outcome of chemoradiotherapy for lung cancer has rarely been studied or addressed. The purpose of our study was to investigate whether splenic volume was associated with prognosis in patients treated with chemoradiotherapy for advanced or locally advanced non-small cell lung cancer (NSCLC). A retrospective investigation was conducted. Finally, 202 patients met the criteria and were included in the study. All patients were divided into 2 groups according to the optimum cutoff value of splenic volume for overall survival (OS). The optimum cutoff value was identified by X-tile software, and the OS and disease-free survival (DFS) were compared between the 2 groups of patients. The impact of splenic volume and other clinical characteristics on OS and DFS was analyzed using the Kaplan–Meier method and Cox proportional hazards model. Clinical characteristics were compared using chi-square or Fisher exact tests. The median (range) of splenic volume was 156.03 (28.55–828.11) cm 3 . The optimal cutoff value of splenic volume was 288.4 cm 3 . For univariate analyses, high splenic volume was associated with decreased OS ( P = .025) and DFS ( P = .044). In multivariate analyses, splenic volume remained an independent predictor of OS as a binary dependent variable ( P = .003). Excessive splenic volume was associated with decreased OS and DFS in patients with NSCLC treated with chemoradiotherapy. Splenic volume should be regarded as an independent prognostic factor for patients treated with chemoradiotherapy for advanced or locally advanced NSCLC.

show abstract

“…of HCC commonly occurs in lung (55%), regional lymph nodes (53%), kidney (42%), bone marrow (38%) and adrenal gland (11%) [2]. Metastasis to spleen is very rare and occurs due to direct extension, from free hematogenous spread or lymphatic invasion [3]. The incidence of splenic metastasis ranged from 0.7-0.8% disseminated cases [4].…”

Section: Fig4: Tumor Cells With Few Atypical Mitosis (H and E×400)mentioning

confidence: 99%

Isolated Splenic Metastasis from Hepatocellular Carcinoma

Sekaran¹,

Yadav²,

Reddy³

et al. 2022

JCR

View full text Add to dashboard Cite

show abstract

Pedunculated hepatocellular carcinoma and splenicmetastasis

Cited by 10 publications

References 10 publications

Giant pedunculated hepatocellular carcinoma masquerading as a pelvic mass: a case report

Giant pedunculated hepatocellular carcinoma masquerading as a pelvic mass: a case report

Excessive splenic volume is an unfavorable prognostic factor in patients with non-small cell lung cancer treated with chemoradiotherapy

Isolated Splenic Metastasis from Hepatocellular Carcinoma

Contact Info

Product

Resources

About